Skip to main navigation Skip to search Skip to main content

Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

  • M. Cruijsen*
  • , W. J.F.M. van der Velden
  • , A. F.J. de Haan
  • , S. K. Klein
  • , M. Hoogendoorn
  • , Y. Tromp
  • , B. de Valk
  • , B. van Rees
  • , F. de Boer
  • , E. van der Spek
  • , J. Pruijt
  • , L. F. Verdonck
  • , E. Vellenga
  • , N. Blijlevens
  • , A. A. van de Loosdrecht
  • , G. Huls
  • *Corresponding author for this work
  • Radboud University Nijmegen
  • Catharina Hospital
  • Meander Medical Center
  • Medical Centre Leeuwarden
  • Ropcke-Zweers Hospital
  • Spaarneziekenhuis
  • Tjongerschans Hospital
  • Ikazia Hospital
  • Rijnstate Hospital
  • Jeroen Bosch Ziekenhuis
  • Isala Clinics
  • University of Groningen

Research output: Contribution to journalLetterAcademicpeer-review

14 Downloads (Pure)
Original languageEnglish
Pages (from-to)2752-2755
Number of pages4
JournalLeukemia and Lymphoma
Volume61
Issue number11
DOIs
Publication statusPublished - Nov 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this